Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases

Federico Carbone, Alessio Nencioni, François Mach, Nicolas Vuilleumier, Fabrizio Montecucco

Research output: Contribution to journalArticlepeer-review


Atherothrombosis is the major determinant of acute ischaemic cardiovascular events, such as myocardial infarction and stroke. Inflammatory processes have been linked to all phases of atherogenesis In particular, the identification of autoimmunity mediators in the complex microenvironment of chronic inflammation has become the focus of attention in both early and advanced atherogenic processes. Autoantibodies against self-molecules or new epitopes generated by oxidative processes infiltrate atherosclerotic plaques and were shown to modulate the activity of immune cells by binding various types of receptors. However, despite mounting evidence for a pathophysiological role of autoantibodies in atherothrombosis, the clinical relevance for circulating autoantibodies in cardiovascular outcomes is still debated. This review aims at illustrating the mechanisms by which different types of autoantibodies might either promote or repress atherothrombosis and to discuss the clinical studies assessing the role of auto-antibodies as prognostic biomarkers of plaque vulnerability.

Original languageEnglish
Pages (from-to)854-868
Number of pages15
JournalThrombosis and Haemostasis
Issue number5
Publication statusPublished - 2013


  • Acute myocardial infarction
  • Atherosclerosis
  • Auto-antibodies
  • Inflammation
  • Stroke

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases'. Together they form a unique fingerprint.

Cite this